Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page
- Check7 days agoChange DetectedRecruitment status was updated to No longer looking for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The label for Intervention/Treatment was standardized and the revision/version label updated to v3.6.0.SummaryDifference0.4%

- Check14 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a small backend/content management system update to this page. This update does not change the visible content or the information presented about the study.SummaryDifference0.1%

- Check21 days agoChange DetectedThe results status changed from 'No Results Posted' to 'Results Submitted', indicating that outcome data are being submitted for posting and will be available after processing.SummaryDifference0.1%

- Check28 days agoChange DetectedA PubMed citation related to the study was added to the Publications section. A line noting that some publications are automatically filled from PubMed was included.SummaryDifference0.2%

- Check35 days agoChange DetectedA new page revision tag, Revision: v3.5.4, was added, replacing the prior Revision: v3.5.3 to reflect an update to the page's version.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s footer revision/version indicator is updated from v3.5.2 to v3.5.3, reflecting a minor site release without changing the underlying study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.